product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF
catalog :
1906-SF-050
quantity :
50 ug
price :
432 USD
more info or order :
product information
master code :
1906-SF
SKU :
1906-SF-050
product name :
Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF
unit size :
50 ug
description :
The Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF from R&D Systems is derived from HEK293. The Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
CRACC/SLAMF7
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Human
observed molecular weight :
65-75 kDa, reducing conditions
theoretical molecular weight :
49 kDa
details of functionality :
Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 1-6 ╡g/mL.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
top caption :
Recombinant Human CRACC/SLAMF7 Fc Chimera Protein Bioactivity
accessionNumbers :
Q9NQ25
applications :
Bioactivity
source long :
Human embryonic kidney cell, HEK293-derived human CRACC/SLAMF7 protein Human SLAMF7 (Ser23-Met226) Accession # Q9NQ25 IEGRMD Human IgG1 (Pro100-Lys330) N-terminus C-terminus
source short :
HEK293
USD :
432 USD
alt names :
19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAMF7
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, <= -20 ░C under sterile conditions after reconstitution.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Recombinant SARS-CoV-2 B.1.351 Spike His-tag Protein, CF | 10777-CV-100
- Recombinant Human CDCP1 Fc Chimera Protein, CF | 10402-CU-050
- Recombinant Cynomolgus Monkey Klotho beta His Protein, CF | 10428-KB-025
- Recombinant Human MICB His-tag Protein, CF | 10431-MB-050
- Recombinant Cynomolgus Angiopoietin-like 3 Protein, CF | 10052-AN-050
questions and comments